vs

Side-by-side financial comparison of ASTRAZENECA PLC (AZN) and T-Mobile US (TMUS). Click either name above to swap in a different company.

T-Mobile US is the larger business by last-quarter revenue ($23.1B vs $14.5B, roughly 1.6× ASTRAZENECA PLC). ASTRAZENECA PLC runs the higher net margin — 16.9% vs 10.8%, a 6.1% gap on every dollar of revenue. On growth, ASTRAZENECA PLC posted the faster year-over-year revenue change (11.7% vs 10.6%).

AstraZeneca plc (AZ) is a Swedish-British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, UK. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.

T-Mobile US, Inc. is an American wireless network operator headquartered in Bellevue, Washington. Its majority shareholder and namesake is the German telecommunications company Deutsche Telekom. T-Mobile is the second largest wireless carrier in the United States, with 140 million subscribers as of September 30, 2025.

AZN vs TMUS — Head-to-Head

Bigger by revenue
TMUS
TMUS
1.6× larger
TMUS
$23.1B
$14.5B
AZN
Growing faster (revenue YoY)
AZN
AZN
+1.1% gap
AZN
11.7%
10.6%
TMUS
Higher net margin
AZN
AZN
6.1% more per $
AZN
16.9%
10.8%
TMUS

Income Statement — Q2 FY2025 vs Q1 FY2026

Metric
AZN
AZN
TMUS
TMUS
Revenue
$14.5B
$23.1B
Net Profit
$2.4B
$2.5B
Gross Margin
82.9%
Operating Margin
24.3%
20.8%
Net Margin
16.9%
10.8%
Revenue YoY
11.7%
10.6%
Net Profit YoY
27.0%
-15.2%
EPS (diluted)
$1.57
$2.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AZN
AZN
TMUS
TMUS
Q1 26
$23.1B
Q4 25
$24.3B
Q3 25
$22.0B
Q2 25
$14.5B
$21.1B
Q1 25
$20.9B
Q4 24
$21.9B
Q3 24
$20.2B
Q2 24
$12.9B
$19.8B
Net Profit
AZN
AZN
TMUS
TMUS
Q1 26
$2.5B
Q4 25
$2.1B
Q3 25
$2.7B
Q2 25
$2.4B
$3.2B
Q1 25
$3.0B
Q4 24
$3.0B
Q3 24
$3.1B
Q2 24
$1.9B
$2.9B
Gross Margin
AZN
AZN
TMUS
TMUS
Q1 26
Q4 25
Q3 25
Q2 25
82.9%
Q1 25
Q4 24
Q3 24
Q2 24
83.1%
Operating Margin
AZN
AZN
TMUS
TMUS
Q1 26
20.8%
Q4 25
15.4%
Q3 25
20.6%
Q2 25
24.3%
24.7%
Q1 25
23.0%
Q4 24
21.0%
Q3 24
23.8%
Q2 24
21.2%
23.4%
Net Margin
AZN
AZN
TMUS
TMUS
Q1 26
10.8%
Q4 25
8.6%
Q3 25
12.4%
Q2 25
16.9%
15.2%
Q1 25
14.1%
Q4 24
13.6%
Q3 24
15.2%
Q2 24
14.9%
14.8%
EPS (diluted)
AZN
AZN
TMUS
TMUS
Q1 26
$2.27
Q4 25
$1.89
Q3 25
$2.41
Q2 25
$1.57
$2.84
Q1 25
$2.58
Q4 24
$2.56
Q3 24
$2.61
Q2 24
$1.24
$2.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AZN
AZN
TMUS
TMUS
Cash + ST InvestmentsLiquidity on hand
$7.1B
$3.5B
Total DebtLower is stronger
$86.0B
Stockholders' EquityBook value
$44.8B
$55.9B
Total Assets
$112.4B
$214.7B
Debt / EquityLower = less leverage
1.54×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AZN
AZN
TMUS
TMUS
Q1 26
$3.5B
Q4 25
$5.6B
Q3 25
$3.3B
Q2 25
$7.1B
$10.3B
Q1 25
$12.0B
Q4 24
$5.4B
Q3 24
$9.8B
Q2 24
$6.9B
$6.4B
Total Debt
AZN
AZN
TMUS
TMUS
Q1 26
$86.0B
Q4 25
$86.3B
Q3 25
Q2 25
Q1 25
Q4 24
$78.3B
Q3 24
Q2 24
Stockholders' Equity
AZN
AZN
TMUS
TMUS
Q1 26
$55.9B
Q4 25
$59.2B
Q3 25
$60.5B
Q2 25
$44.8B
$61.1B
Q1 25
$61.1B
Q4 24
$61.7B
Q3 24
$64.3B
Q2 24
$39.6B
$62.6B
Total Assets
AZN
AZN
TMUS
TMUS
Q1 26
$214.7B
Q4 25
$219.2B
Q3 25
$217.2B
Q2 25
$112.4B
$212.6B
Q1 25
$214.6B
Q4 24
$208.0B
Q3 24
$210.7B
Q2 24
$104.3B
$208.6B
Debt / Equity
AZN
AZN
TMUS
TMUS
Q1 26
1.54×
Q4 25
1.46×
Q3 25
Q2 25
Q1 25
Q4 24
1.27×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AZN
AZN
TMUS
TMUS
Operating Cash FlowLast quarter
$7.2B
Free Cash FlowOCF − Capex
$4.6B
FCF MarginFCF / Revenue
19.9%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
2.88×
TTM Free Cash FlowTrailing 4 quarters
$18.2B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AZN
AZN
TMUS
TMUS
Q1 26
$7.2B
Q4 25
$6.7B
Q3 25
$7.5B
Q2 25
$7.0B
Q1 25
$6.8B
Q4 24
$5.5B
Q3 24
$6.1B
Q2 24
$5.5B
Free Cash Flow
AZN
AZN
TMUS
TMUS
Q1 26
$4.6B
Q4 25
$4.2B
Q3 25
$4.8B
Q2 25
$4.6B
Q1 25
$4.4B
Q4 24
$3.3B
Q3 24
$4.2B
Q2 24
$3.5B
FCF Margin
AZN
AZN
TMUS
TMUS
Q1 26
19.9%
Q4 25
17.2%
Q3 25
21.9%
Q2 25
21.7%
Q1 25
21.0%
Q4 24
15.3%
Q3 24
20.7%
Q2 24
17.6%
Capex Intensity
AZN
AZN
TMUS
TMUS
Q1 26
0.0%
Q4 25
10.1%
Q3 25
12.0%
Q2 25
11.3%
Q1 25
11.7%
Q4 24
10.1%
Q3 24
9.7%
Q2 24
10.3%
Cash Conversion
AZN
AZN
TMUS
TMUS
Q1 26
2.88×
Q4 25
3.16×
Q3 25
2.75×
Q2 25
2.17×
Q1 25
2.32×
Q4 24
1.86×
Q3 24
2.01×
Q2 24
1.89×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AZN
AZN

Segment breakdown not available.

TMUS
TMUS

Postpaid service revenues$15.6B68%
Other$7.5B32%

Related Comparisons